Merck & Co Inc on Tuesday reported a 54.7per cent rise in third-quarter profit, helped by strong sales of blockbuster cancer drug Keytruda and rebound in sales of its key drugs.
Merck quarterly profit rises nearly 55per cent as key drug sales rebound
